Thymogen
Status unknownAlso known as: Oglufanide, 38101-59-6, Glutamyltryptophan, L-Tryptophan, L-alpha-glutamyl-, alpha-Glu-Trp, L-alpha-Glu-L-Trp, oglufanida, 4RHY598T5U
Thymogen (Oglufanide, 38101-59-6, Glutamyltryptophan) is classified under repair & thymosin peptides.
What the research says
Aggregated from the cited literature below. We summarize sources — we don't author claims.
Thymogen (also referred to as Oglufanide; L-Glu-L-Trp) is discussed in the provided sources as a chiral dipeptide with reported immunomodulatory and experimental tissue effects. Research topics in the sources include chirality/enantiomer comparison, oxidative stress/reparative responses in liver injury models, and effects on radiation- or carcinogen-induced tumor development in rodents. A separate review source summarizes authors’ long-term clinical studies using “peptide bioregulators,” including Thymogen.
Key findings (each cites a source)
- A review reported chirality as a factor in peptide/protein interactions and discussed Thymogen as an immunostimulant (L-Glu-L-Trp) in comparison with the enantiomeric immunosuppressor Thymodepressin (D-Glu(D-Trp)). [PMID 38732260]
- Research in an acute toxic hepatopathy model reported that Thymogen and D-Ala–modified analogues suppressed oxidative peroxidation and stimulated reparative regeneration of hepatocytes. [PMID 37861903]
- In the liver damage model, the reported effects of Thymogen analogues were more pronounced than Thymogen, and D-Ala inclusion was reported to enhance regeneration and antioxidant effects, with highest efficiency reported when D-Ala was added to the C-end. [PMID 37861903]
- A rat hepatopathy study reported that thymogen and thymogen analogues with D-alanine attached to the N- or C-terminus inhibited lipid peroxidation and stimulated reparative regeneration of hepatocytes. [PMID 40442470]
- In that hydrazine hepatopathy study, the thymogen analogue reported as most effective was the version with D-Ala at the C-terminus, and increasing the doses beyond stated levels was reported not to further increase hepatoprotective activity. [PMID 40442470]
- In female rat experiments investigating radiation-induced carcinogenesis, a study reported that thymogen inhibited Sr-90/Cs-137-induced radiation carcinogenesis, with decreased total tumor and cancer occurrence, and that thymogen alone was associated with longer life span and lower overall tumor/cancer occurrence in the study design. [PMID 1300740]
- In experimental studies of acute abdominal disorders in rats, research reported thymogen-associated reductions in indicators such as autoenzyme aggression (serum alpha-amylolytic activity) and lipid peroxidation products (malonic dialdehyde), alongside reported attenuation of depression of antiradical activity (superoxide dismutase and catalase) and reduced leukocytosis/leukocyte intoxication index compared with untreated animals. [PMID 9542399]
- In candidiasis under immunodepression, experimental work reported that after thymogen injections the course of candidiasis proceeded less severely, suggesting activation of an immunocompetent system including thymus in that model. [PMID 2337388]
- In a study of esophageal and forestomach tumor development induced by N-nitrososarcosine ethyl ester in rats, thymogen was reported to decrease tumor incidence and reduce tumor multiplicity, while a comparator polypeptide drug was reported not to influence tumor development. [PMID 2759010]
- A review summarized authors’ long-term “clinical study results” regarding peptide bioregulators (including Thymogen) for prevention of diseases and treatment of people of different ages, with emphasis on use as “geroprotectors.” [PMID 24003726]
Independent test grades
No independent third-party test data is available for Thymogen yet. Our test grades are aggregated from Finnrick, which independently tests a subset of research peptides — many approved drugs and newer or niche compounds aren't covered.
Research literature (8)
Consolidated from PubMed — each links to the original record.
- Hepatoprotective Effects of Thymogen Analogues in Hydrazine Hepatopathy in Rats.
Chulanova AA, Smakhtina AM, Mal GS, Bobyntsev II, Smakhtin MY, Mishina ES · Bulletin of experimental biology and medicine · 2025 · PMID 40442470
- The First Reciprocal Activities of Chiral Peptide Pharmaceuticals: Thymogen and Thymodepressin, as Examples.
Deigin V, Linkova N, Vinogradova J, Vinogradov D, Polyakova V, Medvedev D · International journal of molecular sciences · 2024 · PMID 38732260
- Reparative and Antioxidant Effects of New Analogues of Immunomodulator Thymogen in Experimental Model of Liver Damage.
Chulanova AA, Smakhtin MY, Bobyntsev II, Mishina ES, Artyushkova EB, Smakhtina AM · Bulletin of experimental biology and medicine · 2023 · PMID 37861903
- [Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results].
Khavinson VKh, Kuznik BI, Ryzhak GA · Advances in gerontology = Uspekhi gerontologii · 2013 · PMID 24003726
- [Use of thymogen in the treatment of various forms of acute abdominal disorders in an experiment].
Reznikov KM, Filippova OV, Glukhov AA, Griaznov DV, Banin IN · Patologicheskaia fiziologiia i eksperimental'naia terapiia · 1998 · PMID 9542399
- [The effect of the synthetic immunomodulator thymogen on radiation-induced carcinogenesis in rats].
Anisimov VN, Miretskiĭ GI, Morozov VG, Pavel'eva IA, Khavinson VKh · Voprosy onkologii · 1992 · PMID 1300740
- [The effect of a synthetic thymus peptide (thymogen) on the immune system in candidiasis under immunodepression].
Khmel'nitskiĭ OK, Iakovlev GM, Belianin VL, Khavinson VKh, Morozov VG, Deĭgin VI · Arkhiv patologii · 1990 · PMID 2337388
- [Inhibiting effect of thymogen on the development of tumors of the esophagus and forestomach induced by N-nitrososarcosine ethyl ester in rats].
Bespalov VG, Troian DN, Petrov AS, Morozov VG, Khavinson VKh · Eksperimental'naia onkologiia · 1989 · PMID 2759010
FAQ
- What is Thymogen?
- Thymogen (Oglufanide, 38101-59-6, Glutamyltryptophan) is classified under repair & thymosin peptides. Research goals associated with it include immune support.
- Is Thymogen FDA-approved?
- The regulatory status of Thymogen is not established in our sources.
- What does the research on Thymogen say?
- peptideone aggregates 8 references from PubMed for Thymogen. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.